Transplantation, AutologousPeripheral Blood Stem Cell TransplantationBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsBone Marrow TransplantationHematopoietic Stem Cell MobilizationAntigens, CD34Bone and BonesCombined Modality TherapyGranulocyte Colony-Stimulating FactorMelphalanMultiple MyelomaHematopoietic Stem CellsTransplantation ConditioningCyclophosphamideBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsBone Marrow PurgingBlood Transfusion, AutologousLeukapheresisLymphoma, Non-HodgkinHematopoiesisLeukocytes, MononuclearCarmustineHematologic NeoplasmsBusulfanTreatment OutcomeEtoposideThiotepaMyeloablative AgonistsGraft SurvivalRemission InductionBone Marrow DiseasesBone RemodelingPlatelet CountT-LymphocytesBone Marrow ExaminationCytarabineBlood Cell CountCytophagocytosisCells, CulturedHodgkin DiseaseBone Marrow NeoplasmsLymphocytesFlow CytometrySalvage TherapyAntineoplastic Agents, AlkylatingIfosfamideWhole-Body IrradiationTime FactorsNeoplasmsVincristineLymphocyte ActivationRecurrenceLeukemia, Myeloid, AcuteImmunophenotypingTransplantation, HomologousCell SeparationBone DensityStem Cell TransplantationAmyloidosisRecombinant ProteinsBone ResorptionDisease-Free SurvivalLymphomaRetrospective StudiesInfectionFatal OutcomeGranulocyte-Macrophage Colony-Stimulating FactorLymphoma, T-CellDoxorubicinCell DifferentiationColony-Forming Units AssayInterleukin-2Cytotoxicity, ImmunologicFeverAntineoplastic AgentsMice, Inbred C57BLDexamethasonePrednisoneFeasibility StudiesSurvival RateBone NeoplasmsCarboplatinBlood CellsKiller Cells, NaturalNeuroblastomaT-Lymphocytes, CytotoxicFollow-Up StudiesCytomegalovirus InfectionsSurvival AnalysisMonocytesBreast NeoplasmsPrognosisBone DevelopmentLeukocyte CountProspective StudiesAntigens, CDBone Diseases